期刊文献+

氧化酚砷对血液肿瘤细胞系的体外效应 被引量:5

In vitro effects of phenylarsine oxide on hematopoietic malignant cell lines
下载PDF
导出
摘要 目的:了解氧化酚砷(Phenylarsine oxide, PAO)对血液肿瘤细胞系的影响。方法: 8种血液肿瘤系经0.01μmol/L、0.05μmol/L和0.1μmol/L的PAO处理达一定时间后,经台盼蓝排除法计数细胞活力和应用流式细胞仪检测细胞DNA含量分布。结果和结论:在生长抑制和诱导凋亡方面,PAO对血液肿瘤细胞的效应谱相对较广,0.05μmol/L和0.1μmol/L的PAO能抑制某些血液肿瘤细胞的生长,并诱导其凋亡。但是,不同来源的血液肿瘤细胞系对PAO的敏感性不完全相同。 Objective: To investigate effects of phenylarsine oxide (PAO) on hematopoietic maligant cell lines. Methods: Eight cell lines from hematopoietic malignancies were treated with 0. 01 μmol/L, 0. 05 μmol/L and 0. 1μmol/ L of PAO for different days. Cell viability was assessed by trypanblau exclusion, and the distribution of cellular DNA contents was measured on flow cytometry. Results and Conclusion: PAO had a wider effect spectrum on hematopoietic malignant cell lines in terms of growth inhibition and apoptosis induction, and 0. 05 μmol/L and 0. 1μmol/L of PAO could inhibit growth of some hematopoietic malignant cells with or without apoptosis induction. However, cell lines from different origins had the different sensitivity to PAO.
出处 《癌症》 SCIE CAS CSCD 北大核心 2000年第1期27-30,共4页 Chinese Journal of Cancer
关键词 氧化酚砷 血液肿瘤 细胞凋亡 体外效应 Phenylarsine oxide Hematopoietic malignancy Growth inhibition Apoptosis
  • 相关文献

参考文献55

二级参考文献371

共引文献3473

同被引文献60

  • 1王振义.开展砷剂治疗白血病的临床和机制研究[J].中华血液学杂志,1996,17(2):57-57. 被引量:100
  • 2张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬.三氧化二砷注射液治疗72例急性早幼粒细胞白血病[J].中华血液学杂志,1996,17(2):58-60. 被引量:476
  • 3Sahara N,Takeshita A,Kobayashi M,et al.Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway[J].Leuk Lymphoma,2004,45:987-995.
  • 4Sander EA,Alb AM,Nauman EA,et al.Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds[J].J Biomed Mater Res A,2004,70:506-513.
  • 5Massey BL,Wen X,Rohr LR,et al.Resorption rate and biocompatibility characteristics of two polyester ventilation tubes in a guinea pig model[J].Otolaryngol Head Neck Surg,2004,131:921-925.
  • 6Perez C,Sanchez A,Putnam D,et al.Poly (lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA[J].J Contr Rel,2001,75 (1-2):211-224.
  • 7Okassa LN,Marchais H,Douziech-Eyrolles L,et al.Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles[J].Inter J Pharmaceut,2005,302:187-196.
  • 8Choi SH,Park TG.G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method[J].Int J Pharm,2006,311:223-228.
  • 9Haas R,Schmidt TC,Steinbach K,et al.Chromatographic determination of phenylarsenic compounds[J].Fresenius J Anal Chem,1998,361:313-318.
  • 10Yang F,Liang R,Pan YF,et al.Preparation,characterization and in vitro release of ciprofloxacin polylactic acid microspheres[J].J Chin Pharmaceut Sci,2005,14:95-99.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部